"Drying effect" of fructus aurantii components and the mechanism of action based on network pharmacology and in vitro pharmacodynamic validation
Background: Fructus aurantii (FA) is the dried, unripe fruit of the plant Citrus aurantium L. and its cultivated varieties. We investigated the drying effect of FA components and how this drying affect is achieved.Methods: We employed systems pharmacology to predict the components and targets of FA...
Saved in:
Main Authors: | Jing Zhu (Author), Yi Luo (Author), Hengli Tong (Author), Lingyun Zhong (Author), Qianfeng Gong (Author), Yaqi Wang (Author), Ming Yang (Author), Qing Song (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Pharmacological Ingredients of Aurantii Fructus Immaturus and Aurantii Fructus
by: Mingyang Qiu, et al.
Published: (2024) -
Flavonoids from Aurantii Fructus Immaturus and Aurantii Fructus: promising phytomedicines for the treatment of liver diseases
by: Jianzhi Wu, et al.
Published: (2020) -
Multi-Component Comparative Pharmacokinetics in Rats After Oral Administration of Fructus aurantii Extract, Naringin, Neohesperidin, and Naringin-Neohesperidin
by: Jinbin Yuan, et al.
Published: (2020) -
Pharmacokinetic Study of 7 Compounds Following Oral Administration of Fructus Aurantii to Depressive Rats
by: Xianhua Zhang, et al.
Published: (2018) -
A preliminary study on Fructus Aurantii extract against hepatocarcinoma via glycolysis and PD-1/PD-L1 pathway
by: Xi Luo, et al.
Published: (2022)